Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
IDEXX Laboratories (IDXX) PT Raised to Street High $240 at Canaccord
-
IDEXX Laboratories (IDXX) PT Raised to $225 at Canaccord Genuity
-
IDEXX Laboratories (IDXX) PT Raised to $210 at Canaccord Genuity, Street High
-
IDEXX Laboratories (IDXX) PT Raised to $180 at Canaccord Genuity
-
IDEXX Laboratories (IDXX) PT Raised to $98 at Canaccord Genuity Following Vet Survey
-
Canaccord Genuity Remains Bullish After Meeting with IDEXX Labs (IDXX) Management
-
IDEXX Laboratories to Present at Two Investor Conferences
-
Canaccord Genuity Cuts Price Target to $75 on IDEXX Labs (IDXX) Following a Veterinarian Survey
-
Canaccord Genuity Maintains Buy on IDEXX Labs (IDXX) Following Investor Meetings
-
Canaccord Genuity Upgrades IDEXX Laboratories (IDXX) to Buy
-
UPDATE: Canaccord Genuity Starts IDEXX Laboratories (IDXX) at Hold; Leading Provider, But FTC Dragging Feet
-
Canaccord Genuity Q1 Preview on Abaxis Inc. (ABAX): Too Far, Too Fast

